Taipei, Taiwan

Chien-Ling Su

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Chien-Ling Su

Introduction

Chien-Ling Su is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical devices and diagnostics, holding a total of 3 patents. His work focuses on improving patient care through innovative solutions.

Latest Patents

One of his latest patents is a device for pulmonary rehabilitation. This device is designed to provide adjustable resistance for patients during respiratory training, enhancing rehabilitation efficiency. It also accommodates various external parts to assist with medication dosing, information processing, and sputum removal, ensuring an optimal experience for patients during their training. Another significant patent involves a method of detecting antibodies against Japanese Encephalitis Virus (JEV) or Zika Virus (ZIKV) using recombinant baculoviruses. This invention allows for the detection of arthropod-borne viruses in biological samples, aiding in the diagnosis and treatment of infected subjects.

Career Highlights

Chien-Ling Su has worked with esteemed institutions such as Chung Yuan Christian University and Taipei Medical University. His experience in these organizations has contributed to his innovative research and development efforts.

Collaborations

He has collaborated with notable colleagues, including Tzong-Yuan Wu and Szu-Cheng Kuo, further enhancing the impact of his work in the medical field.

Conclusion

Chien-Ling Su's contributions to medical technology through his patents demonstrate his commitment to improving healthcare solutions. His innovative devices and methods are paving the way for advancements in patient rehabilitation and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…